Life Sciences
USA Guide 2024 : USA - Nationwide
Band 4
Contact number
+1 215 994 4000About
Provided by Dechert LLP
In today's competitive landscape, innovative leaders in the healthcare and life sciences industry rely on Dechert to navigate their most complex and demanding transactional, intellectual property and litigation matters anywhere in the world.
We represent clients through all stages of the product life cycle – from discovery through development, clinical testing, promotion and sales. We draw on our antitrust, corporate, dispute resolution (litigation and arbitration) intellectual property, product liability, securities, tax and white collar defense, FCPA and corruption investigations lawyers to provide comprehensive solutions to the industry’s most sophisticated challenges.
With dedicated resources deployed at major life sciences hotbeds across the U.S., Europe and Asia, our global team of lawyers collaborates seamlessly to help clients establish or expand their international presence.
Whether guiding a start-up biotech through its first round of commercially significant funding, executing a strategic acquisition for a large pharmaceutical company, licensing a medical device company’s patents or winning antitrust, securities or patent disputes, our lawyers approach every matter with the resources of a major international firm and the focus and depth of a life sciences boutique.
Chambers Review
Dechert is identified for its ability with regard to contentious matters including patent and antitrust litigation. Strong corporate team assists with capital markets transactions and M&A. The firm is also recommended for patent portfolio management and commercialization in the form of licensing and collaboration deals.
Partners Andrea Reid and David Rosenthal colead Dechert's life sciences practice, and are key contacts at the firm.
Work Highlights
- Dechert advised Chiesi Farmaceutici in its definitive agreement to acquire Amryt Pharma in an all-cash transaction valued at US$1.48 billion.